Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.

The Journal of antimicrobial chemotherapy - 1 Jun 1994

Sirot D, Chanal C, Henquell C, Labia R, Sirot J, Cluzel R

Abstract excerpt

Twenty clinical isolates of Escherichia coli resistant to amoxycillin and ticarcillin, both in combination with clavulanic acid, were studied. The ranges of MICs for these strains as determined by the agar dilution method were as follows: amoxycillin, 2048- > 4096 mg/L; ticarcillin, 512- > 4096 mg/L; piperacillin, 32-256 mg/L; mecillinam, 0.5-8 mg/L; and cephalothin 4-16 mg/L. Combining amoxycillin with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to beta-Lactamases
Share to Escherichia coli

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kinetics

Share to Microbial Sensitivity Tests

Share to Molecular Sequence Data

Share to Mutation

Share to Nucleic Acid Hybridization

Source

Identifiers

PMID: 7928805
DOI: 10.1093/jac/33.6.1117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.PMID 7928805Read ↗

Factors determining resistance to β-lactam combined with β-lactamase inhibitors in <i>Escherichia coli</i>Semantic proximity Read ↗

Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.Semantic proximity Read ↗

Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance.Semantic proximity Read ↗

beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact.Semantic proximity Read ↗

Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coliSemantic proximity Read ↗

Genetic Determinants Underlying the Progressive Phenotype of β-lactam/β-lactamase Inhibitor Resistance in <i>Escherichia coli</i>Semantic proximity Read ↗

Diversity of TEM mutants in Proteus mirabilis.Semantic proximity Read ↗

Use of DNA microarrays for rapid genotyping of TEM beta-lactamases that confer resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.